Pro-Dex Inc (co)
Research Pro-Dex Inc (co) (PDEX) on Bullrun: valuation model: 12.9% overvalued, market cap USD 201.01M, P/E 15.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPDEX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal12.9% overvalued
- Market capUSD 201.01M
- P/E15.3
- Financial periodFY2026
- RevenueUSD 77.55M
- Revenue growth16.5%
- Net incomeUSD 13.66M
- Free cash flowUSD 6.76M
- Gross margin31.4%
Valuation Snapshot
Bullrun's latest valuation model marks Pro-Dex Inc (co) as 12.9% overvalued; latest market cap is USD 201.01M; P/E is 15.3.
Peer valuation comparison
Latest P/E is 15.26x versus a Healthcare sector median of 24.6x (38.0% below).
Latest P/E is 15.26x versus a United States median of 23.85x (36.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 77.55M | USD 13.66M | USD 6.76M | 31.4% | 4.12 | USD 8.19M | USD 18.94M | USD 47.63M |
| FY2025 | USD 66.59M | USD 8.98M | -USD 2.93M | 29.3% | 2.67 | USD 33.00K | USD 15.43M | USD 36.63M |
| FY2024 | USD 53.84M | USD 2.13M | USD 5.24M | 27.0% | 0.6 | USD 2.63M | USD 11.96M | USD 30.87M |
| FY2023 | USD 46.09M | USD 7.07M | USD 4.49M | 27.7% | 1.95 | USD 2.94M | USD 12.80M | USD 31.59M |
| FY2022 | USD 42.04M | USD 4.57M | -USD 2.49M | 31.2% | 1.21 | USD 849.00K | USD 13.59M | USD 25.43M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 201.01M | 15.3 | n/a | n/a |
| 2025 | 2025-12-31 | USD 123.51M | 11.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 152.42M | 23.4 | n/a | n/a |
| 2023 | 2023-12-29 | USD 62.15M | 8.4 | n/a | n/a |
| 2022 | 2022-12-30 | USD 56.93M | 12.6 | n/a | n/a |
| 2021 | 2021-12-31 | USD 84.53M | 18.1 | n/a | n/a |
About Pro-Dex Inc (co)
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Pro-Dex Inc (co) overvalued or undervalued?
Bullrun's valuation model currently marks Pro-Dex Inc (co) as 12.9% overvalued.
What is Pro-Dex Inc (co)'s market cap?
Pro-Dex Inc (co)'s market capitalization is USD 201.01M.
What is Pro-Dex Inc (co)'s P/E ratio?
Pro-Dex Inc (co)'s price-to-earnings (P/E) ratio is 15.3.
What does Pro-Dex Inc (co) do?
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries.